<DOC>
	<DOCNO>NCT00066664</DOCNO>
	<brief_summary>RATIONALE : The presence specific serum protein may allow doctor determine patient mycosis fungoides/cutaneous T-cell lymphoma . PURPOSE : This clinical trial study well blood protein analysis detect mycosis fungoides/cutaneous T-cell lymphoma .</brief_summary>
	<brief_title>Serum Protein Patterns Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma , Psoriasis , Normal Skin</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether computer-assisted , higher-order analysis participant low molecular weight serum protein detect distinctive proteomic pattern participant normal skin v mycosis fungoides/cutaneous T-cell lymphoma v psoriasis . - Determine whether proteomic pattern distinguish various stage cutaneous T-cell lymphoma . OUTLINE : This pilot study . Participants complete general skin health questionnaire undergo whole-body skin examination . Blood sample take analyzed low molecular weight serum proteins mass spectroscopy . PROJECTED ACCRUAL : A total 141-423 participant ( 47-94 healthy volunteer , psoriasis patient , T3 cutaneous T-cell lymphoma patient 141 T1 , T2 , T4 mycosis fungoides patient ) accrue study within 3 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets criteria 1 follow category : Healthy skin volunteer No significant inflammatory neoplastic disease skin internal organ Diagnosis 1 follow skin diseases* : Psoriasis Plaquetype disease Psoriasis Area Severity Index score least 12 Mycosis fungoides/cutaneous Tcell lymphoma Clinical diagnosis T1T4 skin disease compatible pathologic diagnosis NOTE : *Stable worsen disease therapy topical therapy within past 2 week PATIENT CHARACTERISTICS : Age 18 85 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant No known HIV1related diseases No known HTLV1related disease Willing undergo brief skin examination fill questionnaire regard skin general health PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other More 2 week since prior systemic therapy skin disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage I cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage II cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage III cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage IV cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage I mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage II mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage III mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage IV mycosis fungoides/Sezary syndrome</keyword>
</DOC>